Important Group Differences on the Functional Assessment of Cancer Therapy –Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell Carcinoma

The Functional Assessment of Cancer Therapy –Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) is important to gauge clinical benefit in metastatic renal cell carcinoma (mRCC).

Source: Value in Health - May 10, 2018 Category: International Medicine & Public Health Authors: David Cella, Robert J. Motzer, Brian I. Rini, Joseph C. Cappelleri, Krishnan Ramaswamy, Subramanian Hariharan, Bhakti Arondekar, Andrew G. Bushmakin Source Type: research